Oral ibandronate: changes in markers of bone turnover during adequately dosed continuous and weekly therapy and during different suboptimally dosed treatment regimens.
Bone
; 32(6): 687-93, 2003 Jun.
Article
en En
| MEDLINE
| ID: mdl-12810176
Search on Google
Banco de datos:
MEDLINE
Asunto principal:
Osteogénesis
/
Difosfonatos
Tipo de estudio:
Clinical_trials
/
Prognostic_studies
Límite:
Aged
/
Female
/
Humans
/
Middle aged
Idioma:
En
Año:
2003
Tipo del documento:
Article